Cargando…
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study
BACKGROUND: Host inflammation contributes to determine whether SARS-CoV-2 infection causes mild or life-threatening disease. Tools are needed for early risk assessment. METHODS: We studied in 111 COVID-19 patients prospectively followed at a single reference Hospital fifty-three potential biomarkers...
Autores principales: | Lorè, Nicola I., De Lorenzo, Rebecca, Rancoita, Paola M. V., Cugnata, Federica, Agresti, Alessandra, Benedetti, Francesco, Bianchi, Marco E., Bonini, Chiara, Capobianco, Annalisa, Conte, Caterina, Corti, Angelo, Furlan, Roberto, Mantegani, Paola, Maugeri, Norma, Sciorati, Clara, Saliu, Fabio, Silvestri, Laura, Tresoldi, Cristina, Ciceri, Fabio, Rovere-Querini, Patrizia, Di Serio, Clelia, Cirillo, Daniela M., Manfredi, Angelo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521494/ https://www.ncbi.nlm.nih.gov/pubmed/34663207 http://dx.doi.org/10.1186/s10020-021-00390-4 |
Ejemplares similares
-
The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key?
por: Sciorati, Clara, et al.
Publicado: (2023) -
Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study
por: De Lorenzo, Rebecca, et al.
Publicado: (2022) -
Chromogranin A plasma levels predict mortality in COVID-19
por: De Lorenzo, Rebecca, et al.
Publicado: (2022) -
Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy
por: Saluzzo, Francesca, et al.
Publicado: (2021) -
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
por: De Lorenzo , Rebecca, et al.
Publicado: (2021)